pharmaphorum

JUNE 24, 2021

Lucentis has been approved by the FDA since 2006 for wet AMD and is a big earner for both Roche and Novartis, who share rights to the product with Roche selling the drug in the US and Novartis selling it in Europe and other markets.

Diabetes 95

Diabetes Biosimilars Drug Development 95

pharmaphorum

JUNE 8, 2021

All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. In 2001, he joined as a principal scientist in the oncology team in the drug discovery division and associate director at Johnson & Johnson.

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunity 105

pharmaphorum

JANUARY 24, 2023

Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments. Ben Hargreaves finds that the vast amount of genetic data that exists today could help provide a faster, more targeted way of developing new drug candidates.

Immunity 98

Immunity Immunization Drug Development 98

Drug Channels

FEBRUARY 6, 2023

Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net). Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Specialty Pharmacies 74

Specialty Pharmacies Hospitals Drug Development 74

pharmaphorum

SEPTEMBER 18, 2020

However, it withdrew its neuropharmacological drug, Zelmid, which was an SSRI, due to concerns over side effects only a year after it was introduced in 1982. In 1990, the US Food and Drug Administration (FDA) requested Astra to change Losec’s brand name to Prilosec, to avoid confusion with Sanofi-Aventis’ diuretic, Lasix (furosemide).

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

Pharmaceutical Technology

NOVEMBER 24, 2022

We talked to Iain Shaw, Senior Director of 14 C Enabled Drug Development, and Eleanor Row, Executive Director of Commercial, at Quotient Sciences, a drug development and manufacturing accelerator. How does your unique Synthesis-to-Clinic® offering streamline the drug development process? Conclusion.

Labelling 52

Labelling Drug Development Packaging 52

Safe Biologics

OCTOBER 10, 2023

As we intended, this approach has been incredibly successful in controlling costs: the Congressional Budget Office projected drug spending between 2004-2013 to be $770 billion; actual expenses were 45% lower- at $421 billion. – View clip. Clip 4: Panel Discussion – View clip.

Biosimilars 130

Biosimilars Drug Pricing Drug Development 130

Drug Channels

OCTOBER 4, 2021

Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net). Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Drug Development 40

Drug Development 40

Pharmaceutical Technology

AUGUST 26, 2008

.” By the early 2000s AstraZeneca had already realised the critical importance of biotechnology, making a number of strategic investments in biotech companies, Abgenix in 2003, Cambridge Antibody Technology in 2006 and culminating in its acquisition of US biotech firm, Medimmune in April 2007 for £15bn.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 40

European Pharmaceutical Review

FEBRUARY 7, 2023

Key changes are expected to be proposed in relation to the Community Code on medicinal products, the EMA Regulation 726/2004 (the EU’s general pharmaceuticals legislation), the Orphan Regulation 141/2000 and the Pediatric Regulation 1901/2006.

Packaging 117

Packaging Drug Development 117

Pharmaceutical Technology

JULY 23, 2008

Despite the enormous growth being enjoyed by the global oncology market, potential cancer cures are left on laboratory shelves on a regular basis, according to Dr Victoria John, head of clinical partnerships at Cancer Research UK’s Drug Development Office. “Companies shelve research on a regular basis,” she says.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Compounding Biosimilars 40

PharmaShots

FEBRUARY 21, 2023

The company is developing PPMX-T002, an anti-cancer drug with an antibody targeting CDH3 connected with a radioisotope yttrium 90 (90Y). Perseus has been discussing the collaborative development of PPMX-T002 with various RI medical drug-developing companies, including PeptiDream and its subsidiary PDRAdhiopharma.

Dosage 56

Dosage Labelling Immunity Immunization 56

Putting Patients First Blog

APRIL 30, 2024

A blueprint for developing patient-centered core impact sets (PC-CIS). Re: Patient-Focused Drug Development: Collecting Comprehensive and Representative Input; Draft Guidance for Industry, Food and Drug Administration Staff, and Other Stakeholders (Docket No. Medical Decision Making, 36(6), 726-740. McLellan, L.,

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

PharmaShots

FEBRUARY 27, 2023

As a renowned chemist, Dr. Senanayake discussed the need to adopt green chemistry in the process of drug development for cost reduction, timely innovation, and generating less waste than the standard process. Dr. Joe Armstrong Dr. Joe presented on the Blockbuster Drug Januvia: An Innovators Perspective.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

Drug Channels

NOVEMBER 2, 2020

Drug Channels, or any of its employees. Copyright © 2006-2020 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Other restrictions may apply. The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc.,

Hospitals 52

Hospitals Drug Development 52

Safe Biologics

SEPTEMBER 11, 2023

As we intended, this approach has been incredibly successful in controlling costs: the Congressional Budget Office projected drug spending between 2004-2013 to be $770 billion; actual expenses were 45% lower- at $421 billion.

Drug Pricing 150

Drug Pricing Biosimilars Vaccines Drug Development 150

Express Pharma

JANUARY 1, 2025

It has a strong presence across various modalities, such as RNAi, ADC, peptides, lipids and oligonucleotides, and manufacturing techniques, such as flow chemistry, enzymatic processes, biocatalysis and fermentation, offering a broad range of technology capabilities for drug development.

Biosimilars 105

Biosimilars Drug Development 105

Pharmaceutical Technology

JANUARY 26, 2023

The company’s name is perhaps most commonly associated with developing clinical-grade pluripotent stem cells – an offshoot from the scientific milestone of Dolly the Sheep, the world’s first mammal to be successfully cloned from the cell of an adult. Scottish Enterprise was instrumental in setting up RoslinCT and its predecessor, Rosin Cells.

Communication 52

Communication Diabetes Drug Development 52

Drug Channels

FEBRUARY 3, 2025

Rare Disease Summit Download Agenda While the industry has seen heightened focus surrounding rare drug development, weve only scratched the surface. The content of Sponsored Posts does not necessarily reflect the views of HMP Omnimedia, LLC, Drug Channels Institute, its parent company, or any of its employees.

Specialty Pharmacies 52

Specialty Pharmacies Drug Development 52